Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30620668

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2019 Mar 1
First author
Reck M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Mar 1;37(7):529-536. doi: 10.1200/JCO.18.01534.
    note
    Source null
    related pmid
    30676857
    relationship
    Comment in
  2. citation
    Ann Transl Med. 2019 Jul;7(Suppl 3):S127. doi: 10.21037/atm.2019.05.72.
    note
    Source null
    related pmid
    31576334
    relationship
    Comment in
  3. citation
    Ann Transl Med. 2019 Jul;7(Suppl 3):S140. doi: 10.21037/atm.2019.06.35.
    note
    Source null
    related pmid
    31576347
    relationship
    Comment in
  4. citation
    Transl Lung Cancer Res. 2019 Oct;8(5):715-722. doi: 10.21037/tlcr.2019.05.12.
    note
    Source null
    related pmid
    31737509
    relationship
    Comment in
  5. citation
    Transl Lung Cancer Res. 2019 Oct;8(5):728-730. doi: 10.21037/tlcr.2019.04.18.
    note
    Source null
    related pmid
    31737511
    relationship
    Comment in
  6. citation
    Transl Lung Cancer Res. 2019 Oct;8(5):731-737. doi: 10.21037/tlcr.2019.04.17.
    note
    Source null
    related pmid
    31737512
    relationship
    Comment in

Authors and identifiers

  1. name
    Reck M
    type
    Author
  2. name
    Rodríguez-Abreu D
    type
    Author
  3. name
    Robinson AG
    type
    Author
  4. name
    Hui R
    type
    Author
  5. name
    Csőszi T
    type
    Author
  6. name
    Fülöp A
    type
    Author
  7. name
    Gottfried M
    type
    Author
  8. name
    Peled N
    type
    Author
  9. name
    Tafreshi A
    type
    Author
  10. name
    Cuffe S
    type
    Author
  11. name
    O'Brien M
    type
    Author
  12. name
    Rao S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Reck M
    type
    Author
  2. name
    Rodríguez-Abreu D
    type
    Author
  3. name
    Robinson AG
    type
    Author
  4. name
    Hui R
    type
    Author
  5. name
    Csőszi T
    type
    Author
  6. name
    Fülöp A
    type
    Author
  7. name
    Gottfried M
    type
    Author
  8. name
    Peled N
    type
    Author
  9. name
    Tafreshi A
    type
    Author
  10. name
    Cuffe S
    type
    Author
  11. name
    O'Brien M
    type
    Author
  12. name
    Rao S
    type
    Author
bibliography ids
  1. nci-bib-3e6d722f4a41e9d7f5b74bd4
book metadata
content sha256
1589e51d805378f1ec24875cebf692b332f19efaed310f1837e02d2d40bee395
document type
citation
dois
  1. 10.1200/JCO.18.00149
electronic publication date
display
2019 Jan 8
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:30620668
immutable id
pubmed:30620668@1589e51d805378f1ec24875cebf692b332f19efaed310f1837e02d2d40bee395
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
7
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
537-546
volume
37
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Mar 1;37(7):529-536. doi: 10.1200/JCO.18.01534.
    note
    Source null
    related pmid
    30676857
    relationship
    Comment in
  2. citation
    Ann Transl Med. 2019 Jul;7(Suppl 3):S127. doi: 10.21037/atm.2019.05.72.
    note
    Source null
    related pmid
    31576334
    relationship
    Comment in
  3. citation
    Ann Transl Med. 2019 Jul;7(Suppl 3):S140. doi: 10.21037/atm.2019.06.35.
    note
    Source null
    related pmid
    31576347
    relationship
    Comment in
  4. citation
    Transl Lung Cancer Res. 2019 Oct;8(5):715-722. doi: 10.21037/tlcr.2019.05.12.
    note
    Source null
    related pmid
    31737509
    relationship
    Comment in
  5. citation
    Transl Lung Cancer Res. 2019 Oct;8(5):728-730. doi: 10.21037/tlcr.2019.04.18.
    note
    Source null
    related pmid
    31737511
    relationship
    Comment in
  6. citation
    Transl Lung Cancer Res. 2019 Oct;8(5):731-737. doi: 10.21037/tlcr.2019.04.17.
    note
    Source null
    related pmid
    31737512
    relationship
    Comment in
outcomes validated
false
pmid
30620668
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
b6e1b03901fa3761b68a1a912972225ffd823c88e43a8692b576750d424e1508
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 Mar 1
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30620668/
title
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater.

Preserved source evidence · Not medical advice